NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

NZME board told 'compromise or be rolled'
Markets

NZME board told 'compromise or be rolled'

Minority shareholders are falling in behind billionaire Jim Grenon's board coup.

NZ sharemarket steady after Ryman completes capital raise
Markets Market Close

NZ sharemarket steady after Ryman completes capital raise

The S&P/NZX 50 Index closed at 12,209.05, down 40.5 points or 0.33%.

Graham Skellern 13 Mar 2025
Underwriters left with $161m of Ryman stock
Property

Underwriters left with $161m of Ryman stock

Retail investors took up 42% of the shares offered to them in the capital raise.

Gregor Thompson 13 Mar 2025
NZ sharemarket falls 1.3% on uncertainty
Markets Market Close

NZ sharemarket falls 1.3% on uncertainty

The S&P/NZX 50 Index closed at 12,249.55, down 161.42 points or 1.3%.

Graham Skellern 12 Mar 2025